Rani Therapeutics Holdsing s (RANI) PT Raised to $32 at Cantor Fitzgerald
Tweet Send to a Friend
Cantor Fitzgerald analyst Brandon Folkes raised the price target on Rani Therapeutics Holdsing s (NASDAQ: RANI) to $32.00 (from $23.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
